Literature DB >> 20190097

Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias.

Donglin Guo1, Lindon Young, Ying Wu, Luiz Belardinelli, Peter R Kowey, Gan-Xin Yan.   

Abstract

Left ventricular hypertrophy (LVH) is frequently associated with clinical atrial arrhythmias, but little is known about how it causes those arrhythmias. Our previous studies have shown that LVH increases the late sodium current (I(Na-L)) that plays an important role in the genesis of ventricular arrhythmias. We hypothesize that LVH may also induce an upregulation of the I(Na-L) in atrial myocytes, leading to atrial electrical abnormalities. The renovascular hypertension model was used to induce LVH in rabbits. Action potential and membrane current recordings were performed in single myocytes. At a pacing cycle length of 2,000 ms, spontaneous phase-2 early afterdepolarizations (EADs) could be recorded from the left atrial myocytes in 10 of 12 LVH rabbits, whereas no EADs could be elicited in right atrial myocytes of LVH rabbits or atrial myocytes from any of the 12 control rabbits. Spontaneous automaticity (SA) from left atrial myocytes was observed in 9 out of 12 LVH rabbits, but none in right atrial myocytes of LVH rabbits or control rabbits, at a pacing rate of 8,000 ms. The left atrial myocytes of LVH rabbits had a significantly higher density of the I(Na-L) compared with those of control rabbits (0.90 +/- 0.12 in LVH vs. 0.50 +/- 0.08 pA/pF in control, n = 8, P < 0.01). Tetrodotoxin, an I(Na-L) blocker, abolished all atrial EADs and SA at 10 microM. Our results demonstrate that LVH induction results in a significant increase of I(Na-L) in the left atrial myocytes that may render these cells susceptible to the genesis of EADs and SA. The I(Na-L) may serve as a potentially useful ionic target for antiarrhythmic drugs for the treatment of atrial arrhythmias in the setting of LVH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190097     DOI: 10.1152/ajpheart.01145.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.

Authors:  Shaobin Jia; Jiangfan Lian; Donglin Guo; Xiaolin Xue; Chinmay Patel; Lin Yang; Zuyi Yuan; Aiqun Ma; Gan-Xin Yan
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Role of late sodium channel current block in the management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Cardiovasc Drugs Ther       Date:  2013-02       Impact factor: 3.727

Review 3.  The role of late I Na in development of cardiac arrhythmias.

Authors:  Charles Antzelevitch; Vladislav Nesterenko; John C Shryock; Sridharan Rajamani; Yejia Song; Luiz Belardinelli
Journal:  Handb Exp Pharmacol       Date:  2014

Review 4.  The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.

Authors:  John C Shryock; Yejia Song; Sridharan Rajamani; Charles Antzelevitch; Luiz Belardinelli
Journal:  Cardiovasc Res       Date:  2013-06-10       Impact factor: 10.787

Review 5.  The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments.

Authors:  Min Li; Xue Xu; Xinyu Yang; Joey S W Kwong; Hongcai Shang
Journal:  BMC Complement Altern Med       Date:  2017-08-10       Impact factor: 3.659

6.  Implantable Cardioverter-defibrillator Therapy for Syncope: An Educational Example of a Multicomponent Electrocardiographic Differential Diagnosis and the Application of Clinical Trial Data to an Individual Patient.

Authors:  Daniel N Pugliese; James A Reiffel
Journal:  J Innov Card Rhythm Manag       Date:  2019-10-15

7.  Dynamic clamping human and rabbit atrial calcium current: narrowing ICaL window abolishes early afterdepolarizations.

Authors:  Sarah Kettlewell; Priyanka Saxena; John Dempster; Michael A Colman; Rachel C Myles; Godfrey L Smith; Antony J Workman
Journal:  J Physiol       Date:  2019-06-12       Impact factor: 5.182

Review 8.  Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?

Authors:  Balázs Horváth; Norbert Szentandrássy; János Almássy; Csaba Dienes; Zsigmond Máté Kovács; Péter P Nánási; Tamas Banyasz
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-15

Review 9.  Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning.

Authors:  Sarah Rouhana; Anne Virsolvy; Nassim Fares; Sylvain Richard; Jérôme Thireau
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.